@article{d3d8880b674648b097aac093dde0bb92,
title = "Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in cancer clinical trials",
author = "Ethan Basch and Gita Thanarajasingam and Dueck, {Amylou C.}",
note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: EB, GT, and AD receive research funding to their institutions from the National Cancer Institute. EB receives payments as a scientific advisor from Carevive, Navigating Cancer, AstraZeneca, Resilience, N-Power, and Sivan. Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: EB, GT, and AD receive research funding to their institutions from the National Cancer Institute. EB receives payments as a scientific advisor from Carevive, Navigating Cancer, AstraZeneca, Resilience, N-Power, and Sivan. ",
year = "2022",
month = jun,
doi = "10.1177/17407745221093922",
language = "English (US)",
volume = "19",
pages = "274--276",
journal = "Clinical Trials",
issn = "1740-7745",
publisher = "SAGE Publications Ltd",
number = "3",
}